BMS – Consensus statement
Post Reproductive Health · 2018-09 · 24 (3) · 133-138
DOI: 10.1177/2053369118795349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Post Reproductive Health, online erschienen am 23.09.2018. Verfasst von Joan Pitkin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College, Trustee BMS, Daisy Network, UK (previously Consultant Gynaecologist and Director of the Northwick Park Menopause Research and Clini…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Urogenital atrophy is more common than it would first appear and women do not always seek advice and guidance. Confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations but new treatment modalities have emerged that extend the range of options beyond lubricants, moisturisers and vaginal estrogen preparations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Imperial College, Trustee BMS, Daisy Network, UK (previously Consultant Gynaecologist and Director of the Northwick Park Menopause Research and Clinical Unit, UK).
Zitieren
APA
Pitkin, J., & British Menopause Society medical advisory council (2018). BMS – Consensus statement. Post Reproductive Health, 24(3), 133-138. https://doi.org/10.1177/2053369118795349
Vancouver
Pitkin J, British Menopause Society medical advisory council. BMS – Consensus statement. Post Reproductive Health. 2018;24(3):133-138. doi:10.1177/2053369118795349
BibTeX
@article{Pitkin2018,
author = {Pitkin, Joan and British Menopause Society medical advisory council, British Menopause Society medical advisory council},
title = {BMS – Consensus statement},
journal = {Post Reproductive Health},
year = {2018},
volume = {24},
number = {3},
pages = {133--138},
doi = {10.1177/2053369118795349}
}
EUVIMED